Each step in a diagnostic test’s journey—from raw material extraction to patient administration—can influence outcomes. Advances in molecular biology, immunodiagnostics and rapid point-of-care (POC) testing are transforming diagnostics. New products and support services are providing the critical tools and components which enable clinicians to detect specific biomarkers and target treatments, ultimately resulting in better patient outcomes.
Recent events have increased the global focus and commitment on bringing diagnostic tests to market as quickly as possible as well as the challenges the industry has faced in developing and bringing these diagnostic tests to market in exceptional circumstances. A wealth of technology, diverse expertise in areas such as material science, biochemistry, virology as well as a robust supply of critical components are fundamental to the successful development of every test. Optimizing assays and kits for high sensitivity and accuracy is a common goal for all those involved in the development process. The need for close collaboration between diagnostic developers and component and material providers has never been stronger.
We invite you to our thought-provoking and interactive virtual summit showcasing recently launched technologies, products and solutions supporting the development of diagnostics. Incorporating a program of webinars hosted by leading scientists at the University College London (UCL) and Harvard Medical School, a panel discussion from industry experts from DCN and Sona Nanotech as well as sessions from Cytiva’s own product and application specialists. You will also be able to live chat with our product experts.